Skip navigation

7 DRUG INTERACTIONS

Viagra > yellow viagra pill


Studies in vitro have demonstrated that tadalafil is a selective inhibitor of PDE5.

  • The impact of the yellow Viagra pill can vary based on physical health and age.
  • Its use is not recommended for individuals taking certain antifungals or antibiotics.
  • The pill is effective only if the underlying cause of ED is suitable for sildenafil.
  • Discreet packaging is common for online purchases of yellow Viagra pills.
  • The pill’s effectiveness may diminish over time or with inconsistent use.
  • Consult your doctor if you experience no results or adverse effects.

Although tadalafil tablets have not been shown to increase bleeding times in healthy subjects, use in patients with bleeding disorders or significant active peptic ulceration should be based upon a careful risk-benefit assessment and caution.

  • Some yellow Viagra pills are designed for specific markets or regions.
  • The pill's shape, imprint, and color help verify authenticity.
  • Overuse or misuse can lead to serious health consequences including heart issues.
  • Viagra does not protect against sexually transmitted diseases.
  • The yellow Viagra pill has contributed to many people's improved sexual health.
  • Always follow medical advice and instructions when taking Viagra or its variants.

The use of tadalafil tablets offers no protection against sexually transmitted diseases. 6 ADVERSE REACTIONS 6.1 Clinical Trials ExperienceBecause clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.Tadalafil was administered to over 9000 men during clinical trials worldwide.

Side Effects

In trials of tadalafil tablet for once daily use, a total of 1434, 905, and 115 were treated for at least 6 months, 1 year, and 2 years, respectively. For tadalafil tablets for use as needed, over 1300 and 1000 subjects were treated for at least 6 months and 1 year, respectively.Tadalafil Tablets for Use as Needed for EDIn eight primary placebo-controlled clinical studies of 12 weeks duration, mean age was 59 years (range 22 to 88) and the discontinuation rate due to adverse events in patients treated with tadalafil 10 mg or 20 mg was 3.1%, compared to 1.4% in placebo treated patients.When taken as recommended in the placebo-controlled clinical trials, the following adverse reactions were reported (see Table 1) for tadalafil tablets for use as needed:Table 1: Treatment-Emergent Adverse Reactions Reported by ≥2% of Patients Treated with Tadalafil Tablets (10 mg or 20 mg) and More Frequent on Drug than Placebo in the Eight Primary Placebo-Controlled Clinical Studies (Including a Study in Patients with Diabetes) for Tadalafil Tablets for Use as Needed for EDa The term flushing includes: facial flushing and flushingTadalafil Tablet for Once Daily Use for EDIn three placebo-controlled clinical trials of 12 or 24 weeks duration, mean age was 58 years (range 21 to 82) and the discontinuation rate due to adverse events in patients treated with tadalafil was 4.1%, compared to 2.8% in placebo-treated patients.The following adverse reactions were reported (see Table 2) in clinical trials of 12 weeks duration:Table 2: Treatment-Emergent Adverse Reactions Reported by ≥2% of Patients Treated with Tadalafil Tablet for Once Daily Use (2.5 mg or 5 mg) and More Frequent on Drug than Placebo in the Three Primary Placebo-Controlled Phase 3 Studies of 12 weeks Treatment Duration (Including a Study in Patients with Diabetes) for Tadalafil Tablet for Once Daily Use for EDThe following adverse reactions were reported (see Table 3) over 24 weeks treatment duration in one placebo-controlled clinical study:Table 3: Treatment-Emergent Adverse Reactions Reported by ≥2% of Patients Treated with Tadalafil Tablet for Once Daily Use (2.5 mg or 5 mg) and More Frequent on Drug than Placebo in One Placebo-Controlled Clinical Study of 24 Weeks Treatment Duration for Tadalafil Tablet for Once Daily Use for EDTadalafil Tablet for Once Daily Use for BPH and for ED and BPHIn three placebo-controlled clinical trials of 12 weeks duration, two in patients with BPH and one in patients with ED and BPH, the mean age was 63 years (range 44 to 93) and the discontinuation rate due to adverse events in patients treated with tadalafil was 3.6% compared to 1.6% in placebo-treated patients. Adverse reactions leading to discontinuation reported by at least 2 patients treated with tadalafil included headache, upper abdominal pain, and myalgia. The following adverse reactions were reported (see Table 4).Table 4: Treatment-Emergent Adverse Reactions Reported by ≥1% of Patients Treated with Tadalafil Tablet for Once Daily Use (5 mg) and More Frequent on Drug than Placebo in Three Placebo-Controlled Clinical Studies of 12 Weeks Treatment Duration, including Two Studies for Tadalafil Tablet for Once Daily Use for BPH and One Study for ED and BPHAdditional, less frequent adverse reactions (<1%) reported in the controlled clinical viagra red trials of tadalafil tablets for BPH or ED and BPH included: gastroesophageal reflux disease, upper abdominal pain, nausea, vomiting, arthralgia, and muscle spasm.Back pain or myalgia was reported at incidence rates described in Tables 1 through 4. In tadalafil clinical pharmacology trials, back pain or myalgia generally occurred 12 hours to 24 hours after dosing and typically resolved within 48 hours. The back pain/myalgia associated with tadalafil treatment was characterized by diffuse bilateral lower lumbar, gluteal, thigh, or thoracolumbar muscular discomfort and was exacerbated by recumbency. In general, pain was reported as mild or moderate in severity and resolved without medical treatment, but severe back pain was reported with a low frequency (<5% of all reports).

Product Dosage Quantity + Bonus Price
Viagra Original100mg8 Pills59.84€ 56.99€
Viagra Generic50mg30 + 4 Pills54.26€ 51.68€
Viagra Super Active100mg360 + 30 Pills470.93€ 448.50€
Viagra Generic150mg20 Pills55.02€ 52.40€
Viagra Generic200mg90 + 6 Pills170.79€ 162.66€
Viagra Soft Tabs100mg270 + 10 Pills419.95€ 399.95€
Viagra Soft Tabs100mg30 + 4 Pills83.06€ 79.10€
Viagra Generic150mg60 + 4 Pills111.25€ 105.95€
Viagra Oral Jelly100mg21 Sachets78.66€ 74.91€
Viagra Generic200mg20 Pills61.69€ 58.75€

When medical treatment was necessary, acetaminophen or non-steroidal anti-inflammatory drugs were generally effective; however, in a small percentage of subjects who required treatment, a mild narcotic (e.g., codeine) was used. Overall, approximately 0.5% of all subjects treated with tadalafil tablets for on demand use discontinued treatment as a consequence of back pain/myalgia.

12.3 Pharmacokinetics

These events have been chosen for inclusion either due to their seriousness, reporting frequency, lack of clear alternative causation, or a combination of these factors.Cardiovascular and Cerebrovascular - Serious cardiovascular events, including myocardial infarction, sudden cardiac death, stroke, chest pain, palpitations, and tachycardia, have been reported postmarketing in temporal association with the use of tadalafil. Most, but not all, of these patients had preexisting cardiovascular risk factors. Many of these events were reported to occur during or shortly after sexual activity, and a few were reported to occur shortly after the use of tadalafil tablets without sexual activity. Others were reported to have occurred hours to days after the use of tadalafil tablets and sexual activity. It is not possible to determine whether these events are related directly to tadalafil tablets, to sexual activity, to the patient’s underlying cardiovascular disease, to a combination of these factors, or to other factors [see Warnings and Precautions (5.1)].Body as a Whole - hypersensitivity reactions including urticaria, Stevens-Johnson syndrome, and exfoliative dermatitisNervous - migraine, seizure and seizure recurrence, transient global amnesiaOphthalmologic - visual field defect, retinal vein occlusion, retinal artery occlusionNon-arteritic anterior ischemic optic neuropathy (NAION), a cause of decreased vision including permanent loss of vision, has been reported rarely postmarketing in temporal association with the use of PDE5 inhibitors, including tadalafil tablets.

Viagra 50mg Tablet

Most, but not all, of these patients had underlying anatomic or vascular risk factors for development of NAION, including but not necessarily limited to: low cup to disc ratio (“crowded disc”), age over 50, diabetes, hypertension, coronary artery disease, hyperlipidemia, and smoking [see Warnings and Precautions (5.4)].Otologic - Cases of sudden decrease or loss of hearing have been reported postmarketing in temporal association with the use of PDE5 inhibitors, including tadalafil tablets. In the 1-year open label extension study, back pain and myalgia were reported in 5.5% and 1.3% of patients, respectively.

Color Shade Approximate Dose Additional Features Notes
Bright Yellow 100 mg High concentration Prescription-only
Pale Yellow 25 mg Lower dose Suitable for sensitive users
Deep Amber 50 mg Standard dose Most common

Diagnostic testing, including measures for inflammation, muscle injury, or renal damage revealed no evidence of medically significant underlying pathology.

  • There are various brands producing yellow Viagra pills, with slight ingredient variations.
  • The pill can sometimes be identified by its specific shape and markings.
  • Regular monitoring by a healthcare provider is recommended during treatment.
  • Viagra's molecular structure is designed to target specific enzymes related to erections.
  • Consumers should beware of unverified sources selling cheap or suspicious yellow pills.
  • Proper use and adherence to prescribed doses maximize safety and effectiveness.

Incidence rates for tadalafil tablet for once daily use for ED, BPH and BPH/ED are described in Tables 2, 3 viagra jelly sachets uk and 4.

Brand Manufacturer Price Range (per pill) Availability Notes
Pfizer Viagra Pfizer Inc. $15 - $30 Widely available Original brand
YellowPower Generic Labs $5 - $10 Online pharmacies Generic version
MaxiYellow HealthCorp $8 - $18 Pharmacies Alternative brand

In studies of tadalafil tablet for once daily use, adverse reactions of back pain and myalgia were generally mild or moderate with a discontinuation rate of <1% across all indications.Across placebo-controlled studies with tadalafil tablets for use as needed for ED, diarrhea was reported more frequently in patients 65 years of age and older who were treated with tadalafil tablets (2.5% of patients) [see Use in Specific Populations (8.5)].Across all studies with any tadalafil tablets dose, reports of changes in color vision were rare (<0.1% of patients).The following section identifies additional, less frequent events (<2%) reported in controlled clinical trials of tadalafil tablet for once daily use or use as needed. A causal relationship of these events to tadalafil tablet is uncertain. Excluded from this list are those events that were minor, those with no plausible relation to drug use, and reports too imprecise to be meaningful:Body as a Whole - asthenia, face edema, fatigue, pain, peripheral edemaCardiovascular - angina pectoris, chest pain, hypotension, myocardial infarction, postural hypotension, palpitations, syncope, tachycardiaDigestive - abnormal liver function tests, dry mouth, dysphagia, esophagitis, gastritis, GGTP increased, loose stools, nausea, upper abdominal pain, vomiting, gastroesophageal reflux disease, hemorrhoidal hemorrhage, rectal hemorrhageMusculoskeletal - arthralgia, neck painNervous - dizziness, hypesthesia, insomnia, paresthesia, somnolence, vertigoRenal and Urinary - renal impairmentRespiratory - dyspnea, epistaxis, pharyngitisSkin and Appendages - pruritus, rash, sweatingOphthalmologic - blurred vision, changes in color vision, conjunctivitis (including conjunctival hyperemia), eye pain, lacrimation increase, swelling of eyelidsOtologic - sudden decrease or loss of hearing, tinnitusUrogenital - erection increased, spontaneous penile erection6.2 Postmarketing ExperienceThe following adverse reactions have been identified during post approval use of tadalafil tablets.

4. Low blood pressure

In general, pain was reported as mild or moderate in severity and resolved without medical treatment, but severe back pain was reported with a low frequency (<5% of all reports). When medical treatment was necessary, acetaminophen or non-steroidal anti-inflammatory drugs were generally effective; however, in a small percentage of subjects who required treatment, a mild narcotic (e.g., codeine) was used. Overall, approximately 0.5% of all subjects treated with tadalafil tablets for on demand use discontinued treatment as a consequence of back pain/myalgia. In the 1-year open label extension study, back pain and myalgia were reported in 5.5% and 1.3% of patients, respectively. Diagnostic testing, including measures for inflammation, muscle injury, or renal damage revealed no evidence of medically significant underlying pathology.

Common Searches for Imprint

Incidence rates for tadalafil tablet for once daily use for ED, BPH and BPH/ED are described in Tables 2, 3 viagra jelly sachets uk and 4. In studies of tadalafil tablet for once daily use, adverse reactions of back pain and myalgia were generally mild or moderate with a discontinuation rate of <1% across all indications.Across placebo-controlled studies with tadalafil tablets for use as needed for ED, diarrhea was reported more frequently in patients 65 years of age and older who were treated with tadalafil tablets (2.5% of patients) [see Use in Specific Populations (8.5)].Across all studies with any tadalafil tablets dose, reports of changes in color vision were rare (<0.1% of patients).The following section identifies additional, less frequent events (<2%) reported in controlled clinical trials of tadalafil tablet for once daily use or use as needed. A causal relationship of these events to tadalafil tablet is uncertain. Excluded from this list are those events that were minor, those with no plausible relation to drug use, and reports too imprecise to be meaningful:Body as a Whole - asthenia, face edema, fatigue, pain, peripheral edemaCardiovascular - angina pectoris, chest pain, hypotension, myocardial infarction, postural hypotension, palpitations, syncope, tachycardiaDigestive - abnormal liver function tests, dry mouth, dysphagia, esophagitis, gastritis, GGTP increased, loose stools, nausea, upper abdominal pain, vomiting, gastroesophageal reflux disease, hemorrhoidal hemorrhage, rectal hemorrhageMusculoskeletal - arthralgia, neck painNervous - dizziness, hypesthesia, insomnia, paresthesia, somnolence, vertigoRenal and Urinary - renal impairmentRespiratory - dyspnea, epistaxis, pharyngitisSkin and Appendages - pruritus, rash, sweatingOphthalmologic - blurred vision, changes in color vision, conjunctivitis (including conjunctival hyperemia), eye pain, lacrimation increase, swelling of eyelidsOtologic - sudden decrease or loss of hearing, tinnitusUrogenital - erection increased, spontaneous penile erection6.2 Postmarketing ExperienceThe following adverse reactions have been identified during post approval use of tadalafil tablets. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.

Frequently asked questions

Recreational use

These events have been chosen for inclusion either due to their seriousness, reporting frequency, lack of clear alternative causation, or a combination of these factors.Cardiovascular and Cerebrovascular - Serious cardiovascular events, including myocardial infarction, sudden cardiac death, stroke, chest pain, palpitations, and tachycardia, have been reported postmarketing in temporal association with the use of tadalafil.

Country Legal Status Prescription Requirement Remarks
USA Prescription required Yes FDA approved brands only
UK Prescription required Yes Controlled prescription
Canada Prescription required Yes Similar to US
Australia Prescription required Yes Strict regulations

Most, but not all, of these patients had preexisting cardiovascular risk factors.

  • Yellow Viagra should be stored out of reach of children and pets.
  • It is not suitable for use in individuals with severe hypotension or stroke history.
  • The medication can cause priapism, a prolonged erection that requires medical attention.
  • Do not take yellow Viagra if you are allergic to sildenafil or other ingredients.
  • The pill's nutritional compatibility is generally unaffected by diet unless high-fat.
  • Discontinue use and seek medical help if adverse reactions occur.

Many of these events were reported to occur during or shortly after sexual activity, and a few were reported to occur shortly after the use of tadalafil tablets without sexual activity. Others were reported to have occurred hours to days after the use of tadalafil tablets and sexual activity. It is not possible to determine whether these events are related directly to tadalafil tablets, to sexual activity, to the patient’s underlying cardiovascular disease, to a combination of these factors, or to other factors [see Warnings and Precautions (5.1)].Body as a Whole - hypersensitivity reactions including urticaria, Stevens-Johnson syndrome, and exfoliative dermatitisNervous - migraine, seizure and seizure recurrence, transient global amnesiaOphthalmologic - visual field defect, retinal vein occlusion, retinal artery occlusionNon-arteritic anterior ischemic optic neuropathy (NAION), a cause of decreased vision including permanent loss of vision, has been reported rarely postmarketing in temporal association with the use of PDE5 inhibitors, including tadalafil tablets.

5.3 Effects on the Eye

Most, but not all, of these patients had underlying anatomic or vascular risk factors for development of NAION, including but not necessarily limited to: low cup to disc ratio (“crowded disc”), age over 50, diabetes, hypertension, coronary artery disease, hyperlipidemia, and smoking [see Warnings and Precautions (5.4)].Otologic - Cases of sudden decrease or loss of hearing have been reported postmarketing in temporal association with the use of PDE5 inhibitors, including tadalafil tablets.

8.7 Renal Impairment

Studies in vitro have demonstrated that tadalafil is a selective inhibitor of PDE5. Although tadalafil tablets have not been shown to increase bleeding times in healthy subjects, use in patients with bleeding disorders or significant active peptic ulceration should be based upon a careful risk-benefit assessment and caution. The use of tadalafil tablets offers no protection against sexually transmitted diseases. 6 ADVERSE REACTIONS 6.1 Clinical Trials ExperienceBecause clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.Tadalafil was administered to over 9000 men during clinical trials worldwide. In trials of tadalafil tablet for once daily use, a total of 1434, 905, and 115 were treated for at least 6 months, 1 year, and 2 years, respectively.

How should I store tadalafil?

For tadalafil tablets for use as needed, over 1300 and 1000 subjects were treated for at least 6 months and 1 year, respectively.Tadalafil Tablets for Use as Needed for EDIn eight primary placebo-controlled clinical studies of 12 weeks duration, mean age was 59 years (range 22 to 88) and the discontinuation rate due to adverse events in patients treated with tadalafil 10 mg or 20 mg was 3.1%, compared to 1.4% in placebo treated patients.When taken as recommended in the placebo-controlled clinical trials, the following adverse reactions were reported (see Table 1) for tadalafil tablets for use as needed:Table 1: Treatment-Emergent Adverse Reactions Reported by ≥2% of Patients Treated with Tadalafil Tablets (10 mg or 20 mg) and More Frequent on Drug than Placebo in the Eight Primary Placebo-Controlled Clinical Studies (Including a Study in Patients with Diabetes) for Tadalafil Tablets for Use as Needed for EDa The term flushing includes: facial flushing and flushingTadalafil Tablet for Once Daily Use for EDIn three placebo-controlled clinical trials of 12 or 24 weeks duration, mean age was 58 years (range 21 to 82) and the discontinuation rate due to adverse events in patients treated with tadalafil was 4.1%, compared to 2.8% in placebo-treated patients.The following adverse reactions were reported (see Table 2) in clinical trials of 12 weeks duration:Table 2: Treatment-Emergent Adverse Reactions Reported by ≥2% of Patients Treated with Tadalafil Tablet for Once Daily Use (2.5 mg or 5 mg) and More Frequent on Drug than Placebo in the Three Primary Placebo-Controlled Phase 3 Studies of 12 weeks Treatment Duration (Including a Study in Patients with Diabetes) for Tadalafil Tablet for Once Daily Use for EDThe following adverse reactions were reported (see Table 3) over 24 weeks treatment duration in one placebo-controlled clinical study:Table 3: Treatment-Emergent Adverse Reactions Reported by ≥2% of Patients Treated with Tadalafil Tablet for Once Daily Use (2.5 mg or 5 mg) and More Frequent on Drug than Placebo in One Placebo-Controlled Clinical Study of 24 Weeks Treatment Duration for Tadalafil Tablet for Once Daily Use for EDTadalafil Tablet for Once Daily Use for BPH and for ED and BPHIn three placebo-controlled clinical trials of 12 weeks duration, two in patients with BPH and one in patients with ED and BPH, the mean age was 63 years (range 44 to 93) and the discontinuation rate due to adverse events in patients treated with tadalafil was 3.6% compared to 1.6% in placebo-treated patients. Adverse reactions leading to discontinuation reported by at least 2 patients treated with tadalafil included headache, upper abdominal pain, and myalgia. The following adverse reactions were reported (see Table 4).Table 4: Treatment-Emergent Adverse Reactions Reported by ≥1% of Patients Treated with Tadalafil Tablet for Once Daily Use (5 mg) and More Frequent on Drug than Placebo in Three Placebo-Controlled Clinical Studies of 12 Weeks Treatment Duration, including Two Studies for Tadalafil Tablet for Once Daily Use for BPH and One Study for ED and BPHAdditional, less frequent adverse reactions (<1%) reported in the controlled clinical viagra red trials of tadalafil tablets for BPH or ED and BPH included: gastroesophageal reflux disease, upper abdominal pain, nausea, vomiting, arthralgia, and muscle spasm.Back pain or myalgia was reported at incidence rates described in Tables 1 through 4. In tadalafil clinical pharmacology trials, back pain or myalgia generally occurred 12 hours to 24 hours after dosing and typically resolved within 48 hours. The back pain/myalgia associated with tadalafil treatment was characterized by diffuse bilateral lower lumbar, gluteal, thigh, or thoracolumbar muscular discomfort and was exacerbated by recumbency.